AI Navigate
インサイト最新記事一覧AI大全

Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine

THE DECODER / 3/30/2026

📰 NewsSignals & Early TrendsIndustry & Market Moves
Read original →
共有:

Key Points

  • Eli Lilly has signed a $2.75 billion deal with AI drug developer Insilico Medicine, signaling major investment in AI-assisted drug discovery.
  • The agreement reflects Lilly’s strategy to accelerate parts of the drug development pipeline by leveraging AI capabilities in R&D.
  • Insilico Medicine’s positioning as an AI-focused biotech is reinforced by the scale and financial commitment of the partnership.
  • The deal is a market signal that large pharma is increasingly treating AI drug development vendors as strategic collaborators rather than experimental partners.

US pharmaceutical giant Eli Lilly is betting big on AI-driven drug development, signing a $2.75 billion deal with Hong Kong-listed Insilico Medicine.

The article Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine appeared first on The Decoder.

💡 Insights using this article

This article is featured in our daily AI news digest — key takeaways and action items at a glance.

📅 3/30DailyView insight →

関連おすすめサービス

※当サイトはアフィリエイト広告を利用しています
🎧

Notta搭載AI議事録イヤホン ZENCHORD1

AI時代の仕事術。Notta搭載で会議の議事録を自動生成するスマートイヤホン。

🎙️

AI搭載ボイスレコーダー Plaud

世界100万人が愛用。AIで文字起こし・要約を自動化するボイスレコーダー。

🖼️

画像高画質化AIツール Aiarty Image Enhancer

AIで画像を高画質化。写真・イラストを簡単にアップスケール。